[Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist
- PMID: 2153286
- PMCID: PMC53225
- DOI: 10.1073/pnas.87.1.182
[Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist
Abstract
Two types of binding sites have previously been described for 36-amino acid neuropeptide Y (NPY), called Y1 and Y2 receptors. Y2 receptors can bind long C-terminal fragments of NPY-e.g., NPY-(13-36)-peptide. In contrast, Y1 receptors have until now only been characterized as NPY receptors that do not bind such fragments. In the present study an NPY analog is presented, [Leu31, Pro34]NPY, which in a series of human neuroblastoma cell lines and on rat PC-12 cells can displace radiolabeled NPY only from cells that express Y1 receptors and not from those expressing Y2 receptors. The radiolabeled analog, [125I-Tyr36] monoiodo-[Leu31, Pro34]NPY, also binds specifically only to cells with Y1 receptors. The binding of this analog to Y1 receptors on human neuroblastoma cells is associated with a transient increase in cytoplasmic free calcium concentrations similar to the response observed with NPY. [Leu31, Pro34]NPY is also active in vivo as it is even more potent than NPY in increasing blood pressure in anesthetized rats. It is concluded that [Leu31, Pro34]NPY is a specific Y1 receptor agonist and that the analog or variants of it can be useful in delineating the physiological importance of Y1 receptors.
Similar articles
-
Evidence for two neuropeptide Y receptors mediating vasoconstriction.Eur J Pharmacol. 1991 Oct 15;203(2):165-71. doi: 10.1016/0014-2999(91)90711-x. Eur J Pharmacol. 1991. PMID: 1666044
-
Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.Brain Res. 1997 Dec 5;778(1):242-50. doi: 10.1016/s0006-8993(97)01102-5. Brain Res. 1997. PMID: 9462897
-
Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.Eur J Neurosci. 1993 Dec 1;5(12):1622-37. doi: 10.1111/j.1460-9568.1993.tb00231.x. Eur J Neurosci. 1993. PMID: 8124516
-
Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function.Am J Physiol. 1991 Nov;261(5 Pt 1):G701-15. doi: 10.1152/ajpgi.1991.261.5.G701. Am J Physiol. 1991. PMID: 1659217 Review.
-
Neuropeptide Y effector systems: perspectives for drug development.Trends Pharmacol Sci. 1994 May;15(5):153-9. doi: 10.1016/0165-6147(94)90076-0. Trends Pharmacol Sci. 1994. PMID: 7754533 Review.
Cited by
-
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.Br J Pharmacol. 2000 Mar;129(6):1075-88. doi: 10.1038/sj.bjp.0703162. Br J Pharmacol. 2000. PMID: 10725255 Free PMC article.
-
Effects of neuropeptide Y (NPY) and NPY agonists on lordosis in the female guinea pig.Endocrine. 1996 Oct;5(2):169-77. doi: 10.1007/BF02738703. Endocrine. 1996. PMID: 21153108
-
NPY and carbachol raise Ca2+ in SK-N-MC cells by three different mechanisms. Evidence for inositol phosphate-independent Ca2+ mobilization by NPY.Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):370-4. doi: 10.1007/BF00176612. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1620239
-
Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.Br J Pharmacol. 1996 May;118(2):237-42. doi: 10.1111/j.1476-5381.1996.tb15393.x. Br J Pharmacol. 1996. PMID: 8735621 Free PMC article.
-
Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo.Naunyn Schmiedebergs Arch Pharmacol. 1994 Aug;350(2):194-200. doi: 10.1007/BF00241096. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7990977
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous